Furthermore, they postulated that PCSK9 is connected with a higher atherosclerotic burden in psoriasis patients, and, using blood transcript analysis, they identified TNF, IL6, IL17A, and IL23 as PCSK9-related pathways (149). Here, IL6 is linked to psoriasis.